Display options
Cite
Fox JW, Mayer U, Nischt R, et al. Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J. 1991;10(11):3137-46
Fox, J. W., Mayer, U., Nischt, R., Aumailley, M., Reinhardt, D., Wiedemann, H., Mann, K., Timpl, R., Krieg, T., & Engel, J. (1991). Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. The EMBO journal, 10(11), 3137-46.
Fox, J W, et al. "Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV." The EMBO journal vol. 10,11 (1991): 3137-46.
Fox JW, Mayer U, Nischt R, Aumailley M, Reinhardt D, Wiedemann H, Mann K, Timpl R, Krieg T, Engel J. Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J. 1991 Nov;10(11):3137-46. PMID: 1717261; PMCID: PMC453035.
Copy Download .nbib Format: NLM
Share it on
Full text links
Wiley Free PMC Article

EMBO J. 1991 Nov;10(11):3137-46.

Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV.

The EMBO journal

J W Fox, U Mayer, R Nischt, M Aumailley, D Reinhardt, H Wiedemann, K Mann, R Timpl, T Krieg, J Engel

Affiliations

  1. Max-Planck-Institut für Biochemie, Martinsried, FRG.

PMID: 1717261 PMCID: PMC453035
Free PMC Article

Abstract

Recombinant mouse nidogen and two fragments were produced in mammalian cells and purified from culture medium without resorting to denaturing conditions. The truncated products were fragments Nd-I (positions 1-905) comprising the N-terminal globule and rod-like domain and Nd-II corresponding mainly to the C-terminal globule (position 906-1217). Recombinant nidogen was indistinguishable from authentic nidogen obtained by guanidine dissociation from tumor tissue with respect to size, N-terminal sequence, CD spectra and immunochemical properties. They differed in protease stability and shape indicating that the N-terminal domain of the more native, recombinant protein consists of two globules connected by a flexible segment. This established a new model for the shape of nidogen consisting of three globes of variable mass (31-56 kDa) connected by either a rod-like or a thin segment. Recombinant nidogen formed stable complexes (Kd less than or equal to 1 nM) with laminin and collagen IV in binding assays with soluble and immobilized ligands and as shown by electron microscopy. Inhibition assays demonstrated different binding sites on nidogen for both ligands with different specificities. This was confirmed in studies with fragment Nd-I binding to collagen IV and fragment Nd-II binding to laminin fragment P1. In addition, recombinant nidogen but not Nd-I was able to bridge between laminin or P1 and collagen IV. Formation of such ternary complexes implicates a similar role for nidogen in the supramolecular organization of basement membranes.

Similar articles

Zbinden A, Layland SL, Urbanczyk M, Carvajal Berrio DA, Marzi J, Zauner M, Hammerschmidt A, Brauchle EM, Sudrow K, Fink S, Templin M, Liebscher S, Klein G, Deb A, Duffy GP, Crooks GM, Eble JA, Mikkola HKA, Nsair A, Seifert M, Schenke-Layland K.
Adv Sci (Weinh). 2020 Dec 21;8(4):2002500. doi: 10.1002/advs.202002500. eCollection 2021 Feb.
PMID: 33643791

Cited by

Zbinden A, Layland SL, Urbanczyk M, Carvajal Berrio DA, Marzi J, Zauner M, Hammerschmidt A, Brauchle EM, Sudrow K, Fink S, Templin M, Liebscher S, Klein G, Deb A, Duffy GP, Crooks GM, Eble JA, Mikkola HKA, Nsair A, Seifert M, Schenke-Layland K.
Adv Sci (Weinh). 2020 Dec 21;8(4):2002500. doi: 10.1002/advs.202002500. eCollection 2021 Feb.
PMID: 33643791

References

  1. Eur J Biochem. 1988 Dec 1;178(1):71-80 - PubMed
  2. Biochem J. 1985 Nov 1;231(3):571-9 - PubMed
  3. Eur J Biochem. 1987 Jul 1;166(1):11-9 - PubMed
  4. Eur J Biochem. 1989 Sep 1;184(1):241-8 - PubMed
  5. Biochemistry. 1986 Dec 30;25(26):8343-7 - PubMed
  6. J Cell Biol. 1988 Oct;107(4):1599-610 - PubMed
  7. Eur J Biochem. 1986 May 2;156(3):467-78 - PubMed
  8. J Cell Biol. 1990 Sep;111(3):1265-73 - PubMed
  9. FASEB J. 1990 Apr 1;4(6):1577-90 - PubMed
  10. J Biol Chem. 1990 Mar 25;265(9):5188-91 - PubMed
  11. FASEB J. 1990 Feb 1;4(2):148-60 - PubMed
  12. J Biol Chem. 1981 May 25;256(10):5209-14 - PubMed
  13. Eur J Biochem. 1980 Aug;109(1):247-55 - PubMed
  14. Biochemistry. 1984 Apr 10;23(8):1839-50 - PubMed
  15. Mol Immunol. 1980 May;17(5):675-80 - PubMed
  16. Nature. 1978 May 11;273(5658):113-20 - PubMed
  17. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
  18. J Cell Biol. 1991 May;113(3):689-700 - PubMed
  19. EMBO J. 1989 Jan;8(1):65-72 - PubMed
  20. J Cell Biol. 1988 Dec;107(6 Pt 2):2749-56 - PubMed
  21. Dev Biol. 1985 Oct;111(2):372-82 - PubMed
  22. Mol Cell Biol. 1987 Aug;7(8):2745-52 - PubMed
  23. Methods Enzymol. 1987;145:363-91 - PubMed
  24. Cell. 1988 Oct 21;55(2):331-41 - PubMed
  25. Am J Hum Genet. 1989 Jun;44(6):876-85 - PubMed
  26. Anal Biochem. 1988 Aug 15;173(1):93-5 - PubMed
  27. DNA. 1989 Oct;8(8):581-94 - PubMed
  28. Eur J Biochem. 1989 Apr 1;180(3):487-502 - PubMed
  29. J Histochem Cytochem. 1989 Jun;37(6):885-97 - PubMed
  30. J Biol Chem. 1988 Nov 15;263(32):16536-44 - PubMed
  31. Methods Enzymol. 1987;145:3-78 - PubMed
  32. Nucleic Acids Res. 1986 Jun 11;14(11):4617-24 - PubMed
  33. EMBO J. 1985 Oct;4(10):2513-8 - PubMed
  34. Cell. 1985 Jun;41(2):521-30 - PubMed

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources